TTN功能缺失变异与早发房颤的关联
基于Trans-Omics for Precision Medicine项目18 526名个体的全基因组测序,病例对照研究纳入2781例早发房颤患者和4959例欧洲血统对照,发现TTN功能缺失变异与早发房颤显著关联(OR 1.76)。该关联在UK Biobank和MyCode研究中得到重复验证,且发病年龄越早携带变异比例越高。
要点
- TTN功能缺失变异与早发房颤(<66岁)显著相关,OR为1.76。
- 30岁前发病者中6.5%携带TTN功能缺失变异,OR达5.94。
- 关联在独立研究中重复验证,OR为2.16。
核心结论
- TTN基因功能缺失变异与早发房颤存在统计学显著关联,但仅见于小比例早发房颤患者。
- 该关联是否为因果关系尚需进一步研究。
研究设计与样本
- 病例对照研究,纳入2781例早发房颤患者(来自9项研究)和4959例欧洲血统对照。
- 全基因组测序平均深度37.8×,平均基因组覆盖度99.1%。
- 结果在UK Biobank(346 546名参与者)和MyCode研究(42 782名参与者)中重复验证。
主要发现
- 病例组中至少1个TTN功能缺失变异的比例为2.1%,对照组为1.1%(OR 1.76,95%CI 1.04-2.97)。
- 早发房颤患者携带TTN功能缺失变异的比例随发病年龄提前而升高(趋势P=4.92×10⁻⁴)。
- 30岁前发病的房颤患者中6.5%携带TTN功能缺失变异(OR 5.94,95%CI 2.64-13.35;P=1.65×10⁻⁵)。
关键数值与推荐
- 早发房颤定义为发病年龄<66岁。
- 罕见变异分析的显著性阈值为P=4.55×10⁻³。
临床怎么用
- TTN功能缺失变异或可作为早发房颤的风险标记,尤其对年轻发病者。
- 临床解读TTN变异时需结合发病年龄,但当前尚不能用于因果判断。
局限性
- 研究为病例对照设计,无法确定因果关系。
- TTN功能缺失变异仅见于小比例早发房颤患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Atrial fibrillation (AF) is the most common arrhythmia affecting 1% of the population. Young individuals with AF have a strong genetic association with the disease, but the mechanisms remain incompletely understood. OBJECTIVE: To perform large-scale whole-genome sequencing to identify genetic variants related to AF. DESIGN, SETTING, AND PARTICIPANTS: The National Heart, Lung, and Blood Institute's Trans-Omics for Precision Medicine Program includes longitudinal and cohort studies that underwent high-depth whole-genome sequencing between 2014 and 2017 in 18 526 individuals from the United States, Mexico, Puerto Rico, Costa Rica, Barbados, and Samoa. This case-control study included 2781 patients with early-onset AF from 9 studies and identified 4959 controls of European ancestry from the remaining participants. Results were replicated in the UK Biobank (346 546 participants) and the MyCode Study (42 782 participants). EXPOSURES: Loss-of-function (LOF) variants in genes at AF loci and common genetic variation across the whole genome. MAIN OUTCOMES AND MEASURES: Early-onset AF (defined as AF onset in persons <66 years of age). Due to multiple testing, the significance threshold for the rare variant analysis was P = 4.55 × 10-3. RESULTS: Among 2781 participants with early-onset AF (the case group), 72.1% were men, and the mean (SD) age of AF onset was 48.7 (10.2) years. Participants underwent whole-genome sequencing at a mean depth of 37.8 fold and mean genome coverage of 99.1%. At least 1 LOF variant in TTN, the gene encoding the sarcomeric protein titin, was present in 2.1% of case participants compared with 1.1% in control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with early-onset AF who carried a LOF variant in TTN increased with an earlier age of AF onset (P value for trend, 4.92 × 10-4), and 6.5% of individuals with AF onset prior to age 30 carried a TTN LOF variant (OR, 5.94 [95% CI, 2.64-13.35]; P = 1.65 × 10-5). The association between TTN LOF variants and AF was replicated in an independent study of 1582 patients with early-onset AF (cases) and 41 200 control participants (OR, 2.16 [95% CI, 1.19-3.92]; P = .01). CONCLUSIONS AND RELEVANCE: In a case-control study, there was a statistically significant association between an LOF variant in the TTN gene and early-onset AF, with the variant present in a small percentage of participants with early-onset AF (the case group). Further research is necessary to understand whether this is a causal relationship.
引用
- Choi SH, Weng LC, Roselli C, et al. Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. 2018. PMID: 30535219. doi:10.1001/jama.2018.18179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。